Found 0 matching trials
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer PHASE3 Preoperative radiation with single agent chemotherapy as sensitizer is the ...
Show More Location
Multiple Locations
Learn More & Join Trial
Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients PHASE2 * The primary objective of this trial is to assess the safety and feasibili...
Show More Location
Assiut University
Learn More & Join Trial
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer PHASE3 Comparative analysis of the clinical efficacy between primary Total Mesorec...
Show More Location
Daping Hospital, Amy Medeical Univerisity
Learn More & Join Trial
A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer PHASE2 A Phase II Study of Total Neoadjuvant Therapy for High-risk Locally Advance...
Show More Location
Department of Radiation Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Learn More & Join Trial
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer PHASE2 This phase II trial compares atezolizumab in combination with chemotherapy ...
Show More Status
Active Not Recruiting
Location
Kaiser Permanente Dublin
Learn More & Join Trial
Total Neoadjuvant Therapy in Rectal Cancer Treatment PHASE4 This is a randomized, controlled, parallel study to determine the efficienc...
Show More Location
State Scientific Centre of Coloproctology
Learn More & Join Trial
Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer PHASE2 We plan to evaluate the efficacy and safety of cetuximab combined with anti...
Show More Location
Tongji Hospital, Huazhong University of Science and Technology
Learn More & Join Trial